Effect of niraparib on cardiac repolarization in patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer

被引：0
|
作者：
Kathleen Moore
John K. Chan
Angeles Alvarez Secord
Manish R. Patel
Timothy Callahan
Wei Guo
Zhi-Yi Zhang
机构：
[1] University of Oklahoma HSC,Stephenson Cancer Center
[2] Sarah Cannon Research Institute,Palo Alto Medical Foundation, California Pacific Medical Center
[3] Sutter Health Sutter West Bay,undefined
[4] Duke Cancer Institute,undefined
[5] Florida Cancer Specialists and Research Institute,undefined
[6] BioTel Research,undefined
[7] TESARO,undefined
[8] Inc,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2019年 / 83卷
关键词：
Niraparib; PARP inhibitor; Cardiac repolarization; QTc interval; Ovarian cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：717 / 726
页数：9
相关论文
共 50 条
  • [41] Cost-effectiveness of maintenance niraparib with an individualized starting dosage in patients with platinum-sensitive recurrent ovarian cancer in China
    Shi, Yin
    Xiao, Di
    Li, Shuishi
    Liu, Shao
    Zhang, Yu
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [42] DOSE MODIFICATION FOR CHINESE PATIENTS ON NIRAPARIB MAINTENANCE TREATMENT FOR PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: A POST HOC ANALYSIS
    Liu, Z.
    Wu, X.
    Zhu, J.
    Yin, R.
    Yang, J.
    Liu, J.
    Wang, J.
    Wu, L.
    Tan, T.
    Dong, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A193 - A194
  • [43] Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer
    Sabbatini, Paul
    Dupont, Jakob
    Aghajanian, Carol
    Derosa, Felicia
    Poynor, Elizabeth
    Anderson, Sybil
    Hensley, Martee
    Livingston, Phillip
    Lasonos, Alexia
    Spriggs, David
    McGuire, William
    Reinartz, Silke
    Schneider, Sally
    Grande, Cathy
    Lele, Shashikant
    Rodabaugh, Kerry
    Kepner, James
    Ferrone, Soldano
    Odunsi, Kunle
    CLINICAL CANCER RESEARCH, 2006, 12 (18) : 5503 - 5510
  • [44] Budget impact analysis of niraparib and olaparib for maintenance treatment of platinum-sensitive, recurrent ovarian cancer in the US
    Wu, Lei
    Zhong, Lixian
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (02) : 187 - 195
  • [45] Efficacy and safety of niraparib in platinum-sensitive recurrent ovarian cancer: retrospective observational study in a tertiary hospital
    Prado-Mel, Elena
    Suarez-Casillas, Paloma
    Rodriguez-de Francisco, Lupe
    Estevez-Garcia, Purificacion
    Jimenez-Galan, Rocio
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024,
  • [46] NEW MAINTENANCE TREATMENT FOR RECURRENT OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2018, 118 (08) : 25 - 26
  • [47] Gemcitabine plus cisplatin in recurrent ovarian, fallopian tube, and primary peritoneal cancer
    Eyada, Mostafa
    Fellman, Bryan M.
    Patel, Shrina
    Michael, Victoria
    Soliman, Pamela T.
    Sims, Travis T.
    How, Jeffrey Andrew
    Jazaeri, Amir A.
    Fleming, Nicole D.
    Ramondetta, Lois M.
    Westin, Shannon Neville
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [48] Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review
    Zagouri, Flora
    Sergentanis, Theodoros N.
    Chrysikos, Dimosthenis
    Dimopoulos, Meletios-Athanassios
    Bamias, Aristotle
    ONCOTARGETS AND THERAPY, 2015, 8 : 2187 - 2198
  • [49] Efficacy and safety of tivozanib in recurrent, platinum-resistant ovarian, fallopian tube or primary peritoneal cancer.
    Swetzig, Wendy M.
    Lurain, John Robert
    Berry, Emily
    Pineda, Mario Javier
    Shahabi, Shohreh
    Perry, La Toya
    Neubauer, Nikki Lynn
    Nieves-Neira, Wilberto
    Schink, Julian C.
    Schiller, Alissa
    Novak, Karen
    Anderson, Nancy Jean
    Burdett, Kirsten Bell
    Strohl, Anna Everett
    Kocherginsky, Masha
    Matei, Daniela
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] A phase II study of GM-CSF and rIFN-γ1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer
    Schmeler, Kathleen M.
    Vadhan-Raj, Saroj
    Ramirez, Pedro T.
    Apte, Sachin M.
    Cohen, Lorenzo
    Bassett, Roland L.
    Iyer, Revathy B.
    Wolf, Judith K.
    Levenback, Charles L.
    Gershenson, David M.
    Freedman, Ralph S.
    GYNECOLOGIC ONCOLOGY, 2009, 113 (02) : 210 - 215
12345